March 2023

Results:

Discover how you can play a role in the ABTA’s five-year campaign “Meet Hope Head On.”

ABTA Founder Susan Kramer reflects on the last 50 years and her unrelenting pursuit toward finding a cure.

See what’s igniting hope at the nation’s largest brain tumor conference and how you can get involved.

David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.

**Sponsored Content**

For adult patients with recurrent GBM, a new clinical trial may offer access to emerging solutions and novel therapies unavailable elsewhere.

Meet the newly-appointed ABTA Board Chair and Member and discover what they’re hopeful for in their new roles.